Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (151-160 of 450) with videos related to

Pageof 45
Sort By:
World Journal of Oncology|October 7, 2017
Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in ItalyFederica Mazzuca, Marina Borro, Andrea Botticelli, et al.
Lymphatic Research and Biology|April 11, 2022
Cross-Cultural Adaptation and Preliminary Validation of Upper Limb Lymphedema Quality of Life Questionnaire (ULL-27) in Italian Female Patients with Breast Cancer-Related LymphedemaTonia Samela, Roberto Bartoletti, Valeria Antinone, et al.
Frontiers in Oncology|April 10, 2023
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targetsMichela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, et al.
Radiation Oncology (London, England)|November 16, 2019
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experienceMaurizio Valeriani, Luca Marinelli, Serena Macrini, et al.
Annals of Hematology|August 29, 2020
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimabAlessio Di Prima, Andrea Botticelli, Emilia Scalzulli, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Oncotarget|March 12, 2016
Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohortFederica Mazzuca, Marina Borro, Andrea Botticelli, et al.
Frontiers in Oncology|October 11, 2021
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate CancerMaria Massaro, Giuseppe Facondo, Gianluca Vullo, et al.
Investigational New Drugs|June 3, 2008
Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'-aminostilbene for optimization and use in cancer therapyDavid E Durrant, Joanna Richards, Ashutosh Tripathi, et al.
The Eurasian Journal of Medicine|March 31, 2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant TherapyFederica Mazzuca, Andrea Botticelli, Eva Mazzotti, et al.
Pageof 45

Showing results (151-160 of 450) with videos related to

Sort By:
Pageof 45
World Journal of Oncology|October 7, 2017
Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in ItalyFederica Mazzuca, Marina Borro, Andrea Botticelli, et al.
Lymphatic Research and Biology|April 11, 2022
Cross-Cultural Adaptation and Preliminary Validation of Upper Limb Lymphedema Quality of Life Questionnaire (ULL-27) in Italian Female Patients with Breast Cancer-Related LymphedemaTonia Samela, Roberto Bartoletti, Valeria Antinone, et al.
Frontiers in Oncology|April 10, 2023
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targetsMichela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, et al.
Radiation Oncology (London, England)|November 16, 2019
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experienceMaurizio Valeriani, Luca Marinelli, Serena Macrini, et al.
Annals of Hematology|August 29, 2020
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimabAlessio Di Prima, Andrea Botticelli, Emilia Scalzulli, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Oncotarget|March 12, 2016
Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohortFederica Mazzuca, Marina Borro, Andrea Botticelli, et al.
Frontiers in Oncology|October 11, 2021
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate CancerMaria Massaro, Giuseppe Facondo, Gianluca Vullo, et al.
Investigational New Drugs|June 3, 2008
Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'-aminostilbene for optimization and use in cancer therapyDavid E Durrant, Joanna Richards, Ashutosh Tripathi, et al.
The Eurasian Journal of Medicine|March 31, 2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant TherapyFederica Mazzuca, Andrea Botticelli, Eva Mazzotti, et al.
Pageof 45